norfloxacin has been researched along with Hepatitis B in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eandi, M | 1 |
| Viano, I | 1 |
| Di Nola, F | 1 |
| Leone, L | 1 |
| Genazzani, E | 1 |
1 other study available for norfloxacin and Hepatitis B
| Article | Year |
|---|---|
Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.
Topics: Adult; Aged; Anti-Infective Agents; Female; Hepatitis B; Humans; Kidney Failure, Chronic; Kinetics; | 1983 |